AVEO Oncology (AVEO) Announces Restructuring; Will Explore Ficlatuzumab Development Via Collaboration
Tweet Send to a Friend
AVEO Oncology (NASDAQ: AVEO) announced a strategic restructuring designed to optimize resources and reduce expenses to ensure AVEO is well ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


